Skip to main content
PMCB logo

PMCB · PharmaCyte Biotech, Inc. · Short Interest

Track PMCB — free
$0.41 -0.02 (-3.98%)
Market Cap
$4.73M
Shares
10.74M
Volume · Oct 7 97.5K Avg daily vol (3M) 202.06K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

PMCB Latest Reported Short Interest

FINRA reported 70,436 PMCB shares sold short as of the September 15, 2026 settlement date, a decrease of 9,357 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

PMCB Short Interest Forecast

Equibles' model estimates 144,407 shares sold short for the September 30, 2026 settlement, +105.0% versus the latest reported position, with a likely range of 63,507 to 356,489 shares. This model prediction uses FINRA data through September 30, 2026; FINRA's official release is expected October 9, 2026.

Model estimate

Expected Sep 30 short interest

as of Sep 30 High confidence 85% chance it rises
144,407 +105.0% vs reported
Likely range 63,507 to 356,489 The latest estimate appears in the chart below. Official release expected Oct 9. Methodology
Short Squeeze Score
28/100
Short interest 0.7% of shares — P36 Days to cover 1.0 — P13 Price vs VWAP -11.7% — P27 Short-volume trend +0.2% — P47 Short interest change -11.7% — P19 Worst FTD 0.00% of shares — P17

Positioning score 28.0 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-07 20:42 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 Scheduled
FINRA publishes Oct 9
— — — —
2026-09-15 70,436 79,793 -9,357 1.00
2026-08-31 79,793 208,161 -128,368 1.00
2026-08-14 208,161 291,960 -83,799 2.08
2026-07-31 291,960 322,410 -30,450 1.91
2026-07-15 322,410 326,126 -3,716 4.26
2026-06-30 326,126 350,616 -24,490 3.15
2026-06-15 350,616 376,378 -25,762 2.80
2026-05-29 376,378 469,898 -93,520 1.54
2026-05-15 469,898 102,979 +366,919 1.23
2026-04-30 102,979 84,833 +18,146 1.02
2026-04-15 84,833 97,390 -12,557 1.00
2026-03-31 97,390 96,921 +469 1.00
2026-03-13 96,921 106,373 -9,452 1.00
2026-02-27 106,373 140,630 -34,257 1.06
2026-02-13 140,630 179,649 -39,019 1.00
2026-01-30 179,649 177,318 +2,331 1.00
2026-01-15 177,318 62,893 +114,425 1.00
2025-12-31 62,893 635,629 -572,736 1.00
2025-12-15 635,629 925,578 -289,949 1.00
2025-11-28 925,578 469,147 +456,431 1.00
2025-11-14 469,147 480,399 -11,252 11.50
2025-10-31 480,399 480,486 -87 10.95
2025-10-15 480,486 433,065 +47,421 7.11

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1157075 CUSIP 71715X203 Visit website Investor relations